{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:26:37Z","timestamp":1785403597508,"version":"3.56.0"},"reference-count":32,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cannabidiol (CBD), a substance that belongs to the phytocannabinoids, appears to exert antioxidant, neuroprotective, antipsychotic, anticonvulsant, and anticancer properties. Recent evidence supports the immunoregulatory effect of CBD on autoimmune and\/or inflammatory disease. Psoriasis is a chronic skin disease. The main immune cell population involved in the pathogenesis of the disease is the interleukin- (IL-) 17-producing T helper (Th) 17 subset. Other subpopulations, such as interferon-\u03b3 (IFN\u03b3) -producing Th1 and T cytotoxic (Tc) 1, IL-17-producing Tc17, as well as natural killer (NK) and natural killer T cells (NKT) have been implicated in psoriasis development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      The aim of the present study was to evaluate the\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      effect of CBD on the aforementioned subpopulations isolated from patients with psoriasis using flow cytometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Cells were stimulated in the presence or absence of CBD, stained and examined using surface and intracellular markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CBD decreased IL-17 production within the CD3, Th, and NKT cell compartments and IFN\u03b3 production within the CD3 compartment in cells isolated from patients with psoriasis. Interestingly, CBD supplementation did not inhibit production of proinflammatory cytokines in cells isolated from healthy individuals. On the contrary, IFN\u03b3-producing Th, Tc, and NK cells increased after CBD supplementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CBD provides anti-inflammatory effects in T cells isolated from patients with psoriasis. Our results could be the impetus for future investigations regarding the immunomodulatory properties of CBD and its utilization for development of CBD-containing antipsoriatic agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2023.0237","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T14:22:51Z","timestamp":1704464571000},"page":"134-146","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Cannabidiol Mediates\n                    <i>In Vitro<\/i>\n                    Attenuation of Proinflammatory Cytokine Responses in Psoriatic Disease"],"prefix":"10.1177","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-7281","authenticated-orcid":false,"given":"Sotirios G.","family":"Tsiogkas","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2512-2840","authenticated-orcid":false,"given":"Konstantina","family":"Apostolopoulou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia D.","family":"Papagianni","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-1323","authenticated-orcid":false,"given":"Athanasios","family":"Mavropoulos","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-641X","authenticated-orcid":false,"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-7292","authenticated-orcid":false,"given":"Efterpi","family":"Zafiriou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-7902","authenticated-orcid":false,"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.147181"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080827"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112163"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2020.01.014"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225667"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2018.06.009"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0073"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-021-09982-7"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.06.022"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.06.029"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-013-9493-1"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15026-z"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.12.014"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11124"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2012.15"},{"key":"e_1_3_8_17_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00242","article-title":"Innate lymphocytes in psoriasis","volume":"11","author":"Polese B","year":"2020","unstructured":"Polese B, , Zhang H, , Thurairajah B, et al. Innate lymphocytes in psoriasis. Front Immunol, 2020; 11(February):1\u201313; doi: 10.3389\/fimmu.2020.00242","journal-title":"Front Immunol"},{"key":"e_1_3_8_18_2","first-page":"248317","article-title":"NK cells and psoriasis","volume":"2011","author":"Dunphy S","year":"2011","unstructured":"Dunphy S, , Gardiner CM. NK cells and psoriasis. J Biomed Biotechnol, 2011; 2011:248317; doi: 10.1155\/2011\/248317","journal-title":"J Biomed Biotechnol"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6400"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020210"},{"issue":"2","key":"e_1_3_8_21_2","first-page":"e93","article-title":"A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars","volume":"170","author":"Palmieri B","year":"2019","unstructured":"Palmieri B, , Laurino C, , Vadal\u00e0 M. A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. Clin Ter, 2019; 170(2):e93\u2013e99; doi: 10.7417\/CT.2019.2116","journal-title":"Clin Ter"},{"key":"e_1_3_8_22_2","first-page":"0123456789","article-title":"Delphinidin diminishes in vitro interferon-\u03b3 and interleukin-17 producing cells in patients with psoriatic disease","author":"Tsiogkas SG","year":"2021","unstructured":"Tsiogkas SG, , Mavropoulos \u0391, Skyvalidas DN, et al. Delphinidin diminishes in vitro interferon-\u03b3 and interleukin-17 producing cells in patients with psoriatic disease. Immunol Res, 2021:0123456789; doi: 10.1007\/s12026-021-09251-y","journal-title":"Immunol Res"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110728"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.12.004"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0273-0"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28196907"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0183"},{"issue":"3","key":"e_1_3_8_30_2","first-page":"163","article-title":"Serum interferon-gamma is a psoriasis severity and prognostic marker","volume":"84","author":"Abdallah MA","year":"2009","unstructured":"Abdallah MA, , Abdel-Hamid MF, , Kotb AM, et al. Serum interferon-gamma is a psoriasis severity and prognostic marker. Cutis, 2009; 84(3):163\u2013168.","journal-title":"Cutis"},{"key":"e_1_3_8_31_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.932265","article-title":"From IL-17 to IFN-\u03b3 in inflammatory skin disorders: Is transdifferentiation a potential treatment target?","volume":"13","author":"Belpaire A","year":"2022","unstructured":"Belpaire A, , van Geel N, , Speeckaert R. From IL-17 to IFN-\u03b3 in inflammatory skin disorders: Is transdifferentiation a potential treatment target?. Front Immunol, 2022; 13(July):1\u20138; doi: 10.3389\/fimmu.2022.932265","journal-title":"Front Immunol"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010179"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(91)90160-9"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2023.0237","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2023.0237","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2023.0237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:12:01Z","timestamp":1777385521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2023.0237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2,1]]}},"alternative-id":["10.1089\/can.2023.0237"],"URL":"https:\/\/doi.org\/10.1089\/can.2023.0237","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}